Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely

Matthew C Altman1, Stephen R Reeves2, Andrew R Parker3

  • 1Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Wash; Benaroya Research Institute, Seattle, Wash.

Insights

Respiratory syncytial virus (RSV) infection in children with asthma triggers distinct gene expression in airway cells. This exaggerated interferon response correlates with airway obstruction, suggesting a mechanism for lung function decline.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Respiratory Medicine

Background:

  • Childhood respiratory viral infections, including RSV, are linked to asthma development.
  • Understanding the cellular response to RSV in asthmatic children is crucial for identifying disease mechanisms.

Purpose of the Study:

  • To investigate gene expression patterns in bronchial epithelial cells (BECs) from children with asthma following RSV infection.
  • To determine if these patterns correlate with lung function in the BEC donors.

Main Methods:

  • Primary BECs from children with and without asthma were cultured at an air-liquid interface and infected with RSV.
  • Gene expression was analyzed using RNA sequencing, and lung function was assessed via spirometry.

Main Results:

  • RSV infection significantly increased the expression of 6199 genes in BECs from children with asthma.
  • A subset of 195 genes, enriched for viral response and interferon pathways, showed significantly higher expression in asthmatic children with airway obstruction compared to those without obstruction or healthy controls.

Conclusions:

  • BECs from asthmatic children with obstructive physiology exhibit an amplified type I and III interferon response to RSV infection.
  • This exaggerated interferon response may contribute to lung function decline in a subset of pediatric asthma patients.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
880
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K